Article and Diabetes - Pharmacist Digest

Drug Interactions In Diabetes Care – Our Top 10

Med Ed 101

JANUARY 12, 2025

Treating patients with type II diabetes often requires an array of medications to control blood sugar and manage various comorbidities. In this article, we outline the top 10 drug […] The post Drug Interactions In Diabetes Care – Our Top 10 appeared first on Med Ed 101.

Diabetes

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

PharmaVoice

JUNE 23, 2025

Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Development Library Events Press Releases PharmaVoice 100 Nominate 2024 PV100 2023 PV100 Sign up Search Sign up Search An article from Megablockbusters are the holy grail.

Diabetes

Diabetes Packaging Biosimilars

SEO Campaigns for Pharma Marketing: Strategies to Boost Visibility and Engagement

Pharma Marketing Network

JANUARY 11, 2025

For instance, articles like How Stelara Works for Crohns Disease can establish authority and provide value. Understanding Diabetes Management) with trending topics (e.g., By creating valuable, targeted content, you not only rank higher in search results but also engage your audience more effectively.

Diabetes

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Pharma Marketing Network

DECEMBER 31, 2024

This article breaks down key strategies to help you master pharmaceutical marketing while staying ahead of the curve. For instance, Ozempic campaigns have succeeded by showcasing its dual benefits for managing diabetes and weight loss. So, how can you build trust, boost brand awareness, and still drive sales?

Diabetes

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

JUNE 12, 2025

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Health and Personal Care Stores

Health and Personal Care Stores Diabetes Pharmaceutical Companies Pharmaceutical Companies

Flu Vaccines Are a Go

Pharmacy Times

JULY 16, 2025

link] Download Issue PDF Download RIS Articles in this issue Flu Vaccines Are a Go Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. link] Assessing the impact of state pharmacist vaccination authority on vaccine intake in the US.

Vaccines

Vaccines Insurance Coverage and Processing Pharmacy Technician Community Pharmacies

Grail plans FDA filing for cancer blood test after new trial

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Diabetes

Diabetes Pharmaceutical Companies Pharmaceutical Companies Biosimilars

HCP Targeting in Pharma Marketing

Pharma Marketing Network

JUNE 16, 2025

In this article, we’ll explore the most effective HCP targeting strategies shaping pharma marketing in 2025—from data segmentation and digital tools to content personalization and compliance. Pharma brands know that not all doctors are equal when it comes to prescribing behavior, influence, or engagement preferences.

HIPAA

HIPAA Communication Diabetes

Are you moving to more of an omnichannel marketing approach?

Pharma Marketing Network

MARCH 17, 2025

This article explores why omnichannel marketing is critical for pharma success and how you can implement it effectively. Read more featured articles on Pharma Marketing Network. Table of Contents What is Omnichannel Marketing in Pharma? Return on Investment (ROI): Evaluate how omnichannel efforts impact overall sales and brand growth.

Diabetes

Pharma Email Marketing Solutions for Large Lists

Pharma Marketing Network

JUNE 15, 2025

In this article, we explore pharma email marketing solutions tailored to large lists, with insights on deliverability, segmentation, and data-driven personalization. For example, oncology-focused HCPs may need different resources than those treating Type 2 diabetes.

HIPAA

HIPAA Labelling Communication Diabetes

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

PharmaVoice

JULY 7, 2025

Published July 7, 2025 Amy Baxter Staff Reporter post share post print email license stock via Getty Images Listen to the article 6 min This audio is auto-generated. Estimates vary for how many patients with either obesity or diabetes stop using the drugs, but one 2024 study pegged the discontinuation between 50% and 75% within a year.

Compounding

Compounding Packaging Diabetes

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

ASCO 2025: insights on NALIRIFOX use in metastatic pancreatic ductal adenocarcinoma from the NAPOLI-3 trial. Pharmacy Times. June 5, 2025. Accessed June 23, 2025. Subscribe Now!

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies

Rethinking Glucose Monitoring With AI and Nanomaterials

Pharma Marketing Network

JUNE 13, 2025

By Max Kopp Diabetes care is entering a new era—yet even in 2025, continuous glucose monitors (CGMs) remain out of reach for millions. Despite a decade of innovation, current CGMs often fail to meet the needs of everyday people with type 2 diabetes, particularly those in under-resourced or underserved communities.

Diabetes

Diabetes Specialty Pharmacies

The MEK effect on cancer — a slow and steady approach to drug resistance

PharmaVoice

JULY 8, 2025

Published July 8, 2025 By Kelly Bilodeau post share post print email license Stock via Getty Images Listen to the article 5 min This audio is auto-generated. And if you can do that, cancer becomes a chronic, manageable disease, like diabetes, cardiac disease or HIV. I think we have to control cancer before we cure it.”

Immunization

Immunization Immunity Chemotherapy Packaging

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Pharmacy Times

JUNE 27, 2025

Acalabrutinib plus bendamustine and rituximab may become new standard care for untreated MCL. Cancer Therapy Advisor. June 21, 2024. Accessed March 16, 2025.

Drug Interactions In Diabetes Care – Our Top 10

Megablockbusters are the holy grail. Here’s how drugmakers are getting there.

Trending Sources

SEO Campaigns for Pharma Marketing: Strategies to Boost Visibility and Engagement

Mastering Pharmaceutical Marketing: Strategies to Drive Success in the Pharma Industry

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

Flu Vaccines Are a Go

Grail plans FDA filing for cancer blood test after new trial

HCP Targeting in Pharma Marketing

Are you moving to more of an omnichannel marketing approach?

Pharma Email Marketing Solutions for Large Lists

GLP-1 roadblocks: Discontinuation rates soar as insurers clamp down

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Rethinking Glucose Monitoring With AI and Nanomaterials

The MEK effect on cancer — a slow and steady approach to drug resistance

New Frontline BTK Inhibitor Strategy Gains FDA Approval in Untreated Mantle Cell Lymphoma

Expanding Pneumococcal Vaccinations to Healthy Adults Aged 50 to 64 Years Offers Significant Health, Economic Benefits

Authentic Voices: Influencer Marketing In Pharma’s New Era

Pharmacies Need Strategies to Improve Health Care Access

You Shall Not Pass: Pharmacist Review of Drug-Herb Interactions in Cancer Treatment

Pharmacists Push Forward: Innovative Clinical Solutions Highlighted at McKesson ideaShare 2025

Study Reveals Gaps in GINA Guideline Adherence for Asthma Treatment

Continuous Subcutaneous Lenalidomide Shows Promise in Reducing Toxicity in R/R Multiple Myeloma

Educate Patients About Safe Medication Disposal

USP announces new Advanced Technologies Laboratory to accelerate and scale pharmaceutical manufacturing innovations

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

Transitions of Care Pharmacists Mitigate Readmission Rates for COPD

Beyond Dispensing: How Pharmacists and Technicians Can Expand Services to Meet Patient Needs

Pharmacists Can Provide Travel Health Tips for Patients

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Approves Dupilumb for Treatment of Bullous Pemphigoid

Secondary Analysis Investigates Spillover Effects of Antibiotic Audit and Feedback

Zimislecel Could Pave the Way for a Type 1 Diabetes Cure

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Correct Patient Misconceptions Around Biosimilars

Evaluation of a Pharmacy-Delivered Oncofertility Intervention

The Value of a Medically Integrated Pharmacy to Maximize Cost Avoidance and Reduce Waste of Oral Oncolytic Medications

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

FDA Approves First, Only Single-Pill Triple Combination for Treatment of Hypertension

Daily CBD Use at Consumer-Level Doses May Elevate Liver Enzymes, FDA-Led Trial Shows

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Understanding Biologics and Biosimilars Amid an Evolving Treatment Landscape

Zanubrutinib Outperforms Acalabrutinib in Adjusted Head-to-Head Analysis

Because Ned Said: New Technology Helps Prevent Opioid Overdose

Stay Connected